JPH043985B2 - - Google Patents
Info
- Publication number
- JPH043985B2 JPH043985B2 JP58090464A JP9046483A JPH043985B2 JP H043985 B2 JPH043985 B2 JP H043985B2 JP 58090464 A JP58090464 A JP 58090464A JP 9046483 A JP9046483 A JP 9046483A JP H043985 B2 JPH043985 B2 JP H043985B2
- Authority
- JP
- Japan
- Prior art keywords
- plasma
- blood
- filter
- components
- membrane
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 210000004369 blood Anatomy 0.000 claims description 44
- 239000008280 blood Substances 0.000 claims description 44
- 238000001914 filtration Methods 0.000 claims description 20
- 108010088751 Albumins Proteins 0.000 claims description 19
- 102000009027 Albumins Human genes 0.000 claims description 19
- 239000007788 liquid Substances 0.000 claims description 19
- 102000008946 Fibrinogen Human genes 0.000 claims description 10
- 108010049003 Fibrinogen Proteins 0.000 claims description 10
- 229940012952 fibrinogen Drugs 0.000 claims description 10
- 108010044091 Globulins Proteins 0.000 claims description 9
- 102000006395 Globulins Human genes 0.000 claims description 9
- 239000000306 component Substances 0.000 description 33
- 239000012528 membrane Substances 0.000 description 33
- 239000012530 fluid Substances 0.000 description 12
- 102000004169 proteins and genes Human genes 0.000 description 11
- 108090000623 proteins and genes Proteins 0.000 description 11
- 239000000126 substance Substances 0.000 description 10
- 239000012510 hollow fiber Substances 0.000 description 7
- 238000000034 method Methods 0.000 description 7
- 210000004204 blood vessel Anatomy 0.000 description 4
- 108010074605 gamma-Globulins Proteins 0.000 description 4
- -1 immune complexes Proteins 0.000 description 4
- 229920000642 polymer Polymers 0.000 description 4
- 239000003053 toxin Substances 0.000 description 4
- 231100000765 toxin Toxicity 0.000 description 4
- 108700012359 toxins Proteins 0.000 description 4
- 229920000297 Rayon Polymers 0.000 description 3
- 238000005119 centrifugation Methods 0.000 description 3
- 201000010099 disease Diseases 0.000 description 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 3
- 230000004907 flux Effects 0.000 description 3
- 239000011148 porous material Substances 0.000 description 3
- 208000023275 Autoimmune disease Diseases 0.000 description 2
- 239000004698 Polyethylene Substances 0.000 description 2
- 210000000601 blood cell Anatomy 0.000 description 2
- 239000000706 filtrate Substances 0.000 description 2
- 238000002637 fluid replacement therapy Methods 0.000 description 2
- 102000018358 immunoglobulin Human genes 0.000 description 2
- 239000003058 plasma substitute Substances 0.000 description 2
- 229920000573 polyethylene Polymers 0.000 description 2
- 238000000746 purification Methods 0.000 description 2
- 230000001225 therapeutic effect Effects 0.000 description 2
- 208000027932 Collagen disease Diseases 0.000 description 1
- 102000000989 Complement System Proteins Human genes 0.000 description 1
- 108010069112 Complement System Proteins Proteins 0.000 description 1
- 108010003471 Fetal Proteins Proteins 0.000 description 1
- 102000004641 Fetal Proteins Human genes 0.000 description 1
- 206010019663 Hepatic failure Diseases 0.000 description 1
- 108060003951 Immunoglobulin Proteins 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 102000006386 Myelin Proteins Human genes 0.000 description 1
- 108010083674 Myelin Proteins Proteins 0.000 description 1
- 239000004743 Polypropylene Substances 0.000 description 1
- 230000003172 anti-dna Effects 0.000 description 1
- 239000000427 antigen Substances 0.000 description 1
- 108091007433 antigens Proteins 0.000 description 1
- 102000036639 antigens Human genes 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 239000012503 blood component Substances 0.000 description 1
- 230000000052 comparative effect Effects 0.000 description 1
- 230000000295 complement effect Effects 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 230000008021 deposition Effects 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 230000002349 favourable effect Effects 0.000 description 1
- 208000002672 hepatitis B Diseases 0.000 description 1
- 239000012535 impurity Substances 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 231100000835 liver failure Toxicity 0.000 description 1
- 208000007903 liver failure Diseases 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 210000005012 myelin Anatomy 0.000 description 1
- 239000012466 permeate Substances 0.000 description 1
- 229920000098 polyolefin Polymers 0.000 description 1
- 229920001155 polypropylene Polymers 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 238000009987 spinning Methods 0.000 description 1
- 108010063955 thrombin receptor peptide (42-47) Proteins 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
- A61M1/34—Filtering material out of the blood by passing it through a membrane, i.e. hemofiltration or diafiltration
- A61M1/3472—Filtering material out of the blood by passing it through a membrane, i.e. hemofiltration or diafiltration with treatment of the filtrate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
- A61M1/34—Filtering material out of the blood by passing it through a membrane, i.e. hemofiltration or diafiltration
- A61M1/3472—Filtering material out of the blood by passing it through a membrane, i.e. hemofiltration or diafiltration with treatment of the filtrate
- A61M1/3482—Filtering material out of the blood by passing it through a membrane, i.e. hemofiltration or diafiltration with treatment of the filtrate by filtrating the filtrate using another cross-flow filter, e.g. a membrane filter
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D61/00—Processes of separation using semi-permeable membranes, e.g. dialysis, osmosis or ultrafiltration; Apparatus, accessories or auxiliary operations specially adapted therefor
- B01D61/14—Ultrafiltration; Microfiltration
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Heart & Thoracic Surgery (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Biomedical Technology (AREA)
- Hematology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Vascular Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Anesthesiology (AREA)
- Veterinary Medicine (AREA)
- Water Supply & Treatment (AREA)
- Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- External Artificial Organs (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Centrifugal Separators (AREA)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP58090464A JPS59216057A (ja) | 1983-05-23 | 1983-05-23 | 血漿濾過装置 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP58090464A JPS59216057A (ja) | 1983-05-23 | 1983-05-23 | 血漿濾過装置 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPS59216057A JPS59216057A (ja) | 1984-12-06 |
| JPH043985B2 true JPH043985B2 (fr) | 1992-01-24 |
Family
ID=13999321
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP58090464A Granted JPS59216057A (ja) | 1983-05-23 | 1983-05-23 | 血漿濾過装置 |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JPS59216057A (fr) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2004024216A1 (fr) * | 2002-09-12 | 2004-03-25 | Asahi Medical Co., Ltd. | Membrane et systeme de purification du plasma |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20060129082A1 (en) * | 2002-08-13 | 2006-06-15 | Jacek Rozga | Selective plasma exchange therapy |
-
1983
- 1983-05-23 JP JP58090464A patent/JPS59216057A/ja active Granted
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2004024216A1 (fr) * | 2002-09-12 | 2004-03-25 | Asahi Medical Co., Ltd. | Membrane et systeme de purification du plasma |
Also Published As
| Publication number | Publication date |
|---|---|
| JPS59216057A (ja) | 1984-12-06 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US4350594A (en) | Blood purification using plural ultrafiltration stages | |
| US7556768B2 (en) | Biocompatible devices, systems, and methods for reducing levels of pro-inflammatory or anti-inflammatory stimulators or mediators in the blood | |
| US20110097700A1 (en) | Methods for reducing levels of pro-inflammatory or anti-inflammatory stimulators or mediators in the blood | |
| US20070093739A1 (en) | Selective adsorption devices and systems | |
| US4839055A (en) | Method for treating blood and apparatus therefor | |
| JPH04230853A (ja) | 血漿分離方法 | |
| Kirn | Characteristics of protein removal in hemodiafiltration | |
| US20110004152A1 (en) | Biocompatible devices, systems, and methods for reducing levels of proinflammatory of antiinflammatory stimulators or mediators in the blood | |
| JPH0261265B2 (fr) | ||
| US20050061742A1 (en) | Devices, systems, and methods for reducing levels of pro-inflammatory or anti-inflammatory stimulators or mediators in physiologic fluids | |
| US4968432A (en) | Treatment of liquid including blood components | |
| US5217618A (en) | Plasma purification treatment | |
| EP0589572B1 (fr) | Traitement de liquides physiologiques contenant des proteines | |
| US4832839A (en) | Hemopurification apparatus | |
| Sueoka | Present status of apheresis technologies: Part 1. Membrane plasma separator | |
| JPH043985B2 (fr) | ||
| EP0327005B1 (fr) | Procédé de traitement extracorporel de liquide d'ascite | |
| GB2082475A (en) | Artificial lung device | |
| JPS5846962A (ja) | 血液処理用装置 | |
| US20170266362A1 (en) | System for removal of pro-inflammatory mediators as well as granulocytes and monocytes from blood | |
| JPH0580909B2 (fr) | ||
| JPS6362B2 (fr) | ||
| JPH0211263B2 (fr) | ||
| JPH01256971A (ja) | 白血球除去材及び白血球除去フイルター | |
| JPH019575Y2 (fr) |